Incidence of AIDS-defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998

Journal of Acquired Immune Deficiency Syndromes

Volumn 34, Issue 1, 2003, Pages 84-90

  Franceschi, Silvia ^a   Dal Maso, Luigino ^b   Pezzotti, Patrizio ^c   Polesel, Jerry ^b   Braga, Claudia ^a   Piselli, Pierluca ^d   Serraino, Diego ^d   Tagliabue, Giovanna ^e   Federico, Massimo ^f   Ferretti, Stefano ^g   De Lisi, Vincenzo ^h   La Rosa, Francesco ⁱ   Conti, Ettore ^j   Budroni, Mario ^k   Vicario, Gianni ^b,l   Piffer, Silvano ^m   Pannelli, Franco ⁿ   Giacomin, Adriano ^o   Bellù, Francesco ^p   Tumino, Rosario ^q   Fusco, Mario ^r   Rezza, Giovanni ^c   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^e Registro Tumori Lombardia P V   (Italy)

^f Registro Tumori di Modena   (Italy)

^g Dipto di Med Sperim e Diagnostica   (Italy)

^h Registro Tumori Provincia Parma   (Italy)

ⁱ F La Rosa Registro Tumori Umbro   (Italy)

^j Registro Tumori Popolazione P L   (Italy)

^k Registro Tumori della Provincia di Sassari   (Italy)

^l Registro Tumori Friuli Venezia G   (Italy)

^m Registro Tumori della Provincia di Trento   (Italy)

ⁿ Registro Tumori Provincia Macerata   (Italy)

^o Registro Tumori Provincia Biella   (Italy)

^p Registro Tumori dell'Alto Adige   (Italy)

^q CIVILE M P AREZZO HOSPITAL   (Italy)

^r Regione Campania   (Italy)

more..

Author keywords

AIDS; Incidence; Invasive cervical cancer; Kaposi sarcoma; Linkage; Non Hodgkin lymphoma

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; AIDS DEFINING CANCER; AIDS RELATED COMPLEX; ARTICLE; CANCER; CANCER INCIDENCE; CANCER REGISTRY; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNE DEFICIENCY; ITALY; KAPOSI SARCOMA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; HUMANS; INCIDENCE; ITALY; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; RISK FACTORS; SARCOMA, KAPOSI; UTERINE CERVICAL NEOPLASMS;

EID: 0041412821     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200309010-00013     Document Type: Article

References (44)

1. Goedert JJ, Coté TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet. 1998;351:1833-1839.
2. Frisch M, Biggar RJ, Engels EA, et al. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285:1736-1745.
3. Gallagher B, Wang Z, Schymura MJ, et al. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol. 2001;154:544-556.
4. Franceschi S, Dal Maso L, Arniani S, et al. Linkage of AIDS and cancer registries in Italy. Int J Cancer. 1998;75:831-834.
5. Grulich A, Li Y, McDonald A, et al. Rates of non-AIDS defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS. 2002;16:1155-1161.
6. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monogr Eval Carcinog Risks Hum. Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses. Vol. 67. Lyon: International Agency for Research on Cancer; 1996.
7. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in Human Immunodeficiency Virus-infected adults. J Natl Cancer Inst. 2000;92:1823-1830.
8. Serraino D, Boschini A, Carrieri P, et al. Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS. 2000;14:553-559.
9. Dal Maso L, Serraino D, Franceschi S. Epidemiology of AIDS-related tumours in developed and developing countries. Eur J Cancer. 2001;37:1188-1201.
10. Grulich AE, Li Y, McDonald AM, et al. Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination antiretroviral therapy. AIDS. 2001;15:629-633.
11. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet. 1998;352:1725-1730.
12. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl JMed. 1998;338:853-860.
13. Dal Maso L, Franceschi S, Negri E, et al. Trends of AIDS incidence in Europe and the United States. Soz Praventivmed. 1995;40:239-265.
14. ENAADS European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS Surveillance in Europe. Mid-Year Report 2002. No. 67. Saint-Maurice, France; Institut de Veille Sanitaire 2002.
15. Conti S, Farchi G, Galletti A, et al. La notifica della mortalità per AIDS in Italia (1992): qualità della certificazione e sottonotifica. Giornale Italiano dell'AIDS. 1997:8:12-16.
16. Ajdacic-Gross V, Zellweger U, Wang J, et al. How complete is AIDS surveillance in Europe? An eagle eye comparison with mortality data. J Epidemiol Comm Health. 2001;55:52-56.
17. Franceschi S, Dal Maso L, Arniani S, et al. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Br J Cancer. 1998;78:966-970.
18. Dal Maso L, Franceschi S, Polesel J, et al. Risk of cancer in persons with AIDS in Italy, 1985-98. Br J Cancer. 2003;89:94-100.
19. Istituto Superiore di Sanità. Aggiornamento dei casi di AIDS notificati in Italia al 30 giugno 2002. Notiziario ISS. 2002;15(Suppl 1):1-15. Available at: http://www.iss.it/notiziario/2002/0210/COA1.html.
20. Pezzotti P, Serraino D, Rezza G, et al. The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active antiretroviral therapies, 1982-96. Int J Epidemiol. 1999;28:975-981.
21. Zanetti R, Gafá L, Pannelli F, et al, eds. Cancer in Italy. Incidence Data from Cancer Registries. Vol. 3. 1993-1998. Roma: Il Pensiero Scientifico editore; 2002.
22. Parkin DM, Whelan SL, Ferlay J, et al. eds. Cancer Incidence in Five Continents. Vol. VII. IARC Scientific Publication No. 143. Lyon: IARC; 1997.
23. Parkin DM, Whelan SL, Ferlay J, et al, eds. Cancer Incidence in Five Continents. Vol. VIII. IARC Scientific Publication No. 155. Lyon: IARC; 2002.
24. Dal Maso L, Braga C, Franceschi S. Methodology used for "Software for Automated Linkage in Italy" (SALI). J Biomed Informatics. 2001;34:387-395.
25. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR. 1987;36:S1-S15.
26. Kirk O, Pedersen C, Cozzi-Lepri A, et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood. 2001;98:3406-3412.
27. Ledergerber B, Telenti A, Egger M, for the Swiss HIV Cohort Study. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. BMJ. 1999;319:23-24.
28. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol II. The Design and Analysis of Cohort Studies. IARC Scientific Publication No. 82. Lyon: IARC; 1987:60-71.
29. Dobson AJ, Kuulasmaa K, Ederle E, et al. Confidence intervals for weighted sums of Poisson parameters. Stat Med. 1991;10:457-462.
30. Dorrucci M, Balducci M, Pezzotti P, et al. Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: estimates of the population effect of treatment. J Acquir Immune Defic Syndr. 1999;22:65-70.
31. Groves FD, Linet MS, Travis LB, et al. Cancer Surveillance Series: Non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst. 2000;92:1240-1251.
32. Mbulaiteye S, Biggar RJ, Goedert JJ, et al. Immune deficiency and risk of malignancy among persons with AIDS. J Acquir Immune Defic Syndr. 2003;32:527-533.
33. Cartwright R, Brincker H, Carli PM, et al. The rise in incidence of lymphomas in Europe 1985-1992. Eur J Cancer. 1999;35:627-633.
34. Dal Maso L, Rezza G, Zambon P, et al. Non-Hodgkin lymphoma among young adults with and without AIDS in Italy. Int J Cancer. 2001;93:430-435.
35. Olsen JN, Kovacs WJ. Gonadal steroids and immunity. Endocr Rev. 1996;17:369-384.
36. Pezzotti P, Napoli PA, Acciai S, et al. Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. AIDS. 1999;13:249-255.
37. Carrieri MP, Predier C, Piselli P, et al. Reduced incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int J Cancer. 2003;103:142-144.
38. CASCADE Collaboration. Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol. 2002;31:951-958.
39. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Statist Assoc. 1999;94:496-509.
40. Carbone A. AIDS-related non-Hodgkin's lymphomas: from pathology and molecular pathogenesis to treatment. Hum Pathol. 2002;33:392-404.
41. Biggar RJ, Rosenberg PS, Coté T, and the Multistate AIDS/Cancer Match Study Group. Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS. Int J Cancer. 1996;68:754-758.
42. Coté TR, Biggar RJ, Rosenberg PS, et al. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. Int J Cancer. 1997;73:645-650.
43. Evison J, Jost J, Ledergerber B, et al. HIV-associated non-Hodgkin's lymphoma: highly active antiretroviral therapy improves remission rate of chemotherapy. AIDS. 1999;13:732-734.
44. Dal Maso L, Franceschi S. Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol. 2003;4:110-119